Flavio S. De Carvalho
Goiania, GO, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models.
Journal: Chemico-biological interactions
Published: February 28, 2024
Anti-inflammatory, antinociceptive, and vasorelaxant effects of a new pyrazole compound 5-(1-(2-fluorophenyl)-1H-pyrazol-4-yl)-1H-tetrazole: role of NO/cGMP pathway and calcium channels.
Journal: Canadian journal of physiology and pharmacology
Published: March 03, 2023
Preclinical pharmacokinetics of a promising antineoplastic prototype piperazine-containing compound (LQFM018) in rats by a new LC-MS/MS bioanalytical method.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: December 05, 2022
L-proline transporter inhibitor (LQFM215) promotes neuroprotection in ischemic stroke.
Journal: Pharmacological reports : PR
Published: October 01, 2022
Structure-activity relationship of three new piperazine derivates with anxiolytic-like and antidepressant-like effects.
Journal: Canadian journal of physiology and pharmacology
Published: April 08, 2022
Comparison of Conventional and Microwave Synthesis of Phenyl-1H-pyrazoles and Phenyl-1H-pyrazoles-4-carboxylic Acid Derivatives.
Journal: Current organic synthesis
Published: December 12, 2020
Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways.
Journal: CNS & neurological disorders drug targets
Published: August 07, 2020
Antiangiogenic and antitumoral activity of LQFM126 prototype against B16F10 melanoma cells.
Journal: Chemico-biological interactions
Published: March 11, 2020
Design, synthesis and pharmacological assessment of new pyrazole compounds.
Journal: Inflammopharmacology
Published: March 05, 2020
Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.
Journal: Fundamental & clinical pharmacology
Published: September 25, 2019
Antinociceptive effects of new pyrazoles compounds mediated by the ASIC-1α channel, TRPV-1 and μMOR receptors.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 26, 2018
Toxico-pharmacological evaluations of the small-molecule LQFM166: Inducer of apoptosis and MDM2 antagonist.
Journal: Chemico-biological interactions
Published: February 14, 2018
Last Updated: 09/26/2026